Wayne D Vaccaro

USPTO Granted Patents = 42 (Patent Applications = 3)

CIPO Patents = 2

EPO Patents = 8 (Patent Applications = 4)

Average Co-Inventor Count = 5.9

ph-index = 17

Forward Citations = 740(Granted Patents)

Location History:

Princeton, NJ (US) (1992 - 1997)
Yardley, PA (US) (1995 - 2019)

Company Filing History:

24 out of 3,681

Bristol-myers Squibb Compnay

Years Active: 1992-2019

Loading Chart...

42 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10196387 - Carbazole compounds useful as bromodomain inhibitors (2019-02-05),

2. 10053454 - Carbazole compounds useful as bromodomain inhibitors (2018-08-21),

3. 9751879 - Tricyclic compounds as anticancer agents (2017-09-05),

4. 9725449 - Tricyclic compounds as anticancer agents (2017-08-08),

5. 9556178 - Imidazotriazinecarbonitriles useful as kinase inhibitors (2017-01-31),

6. 9273057 - Imidazotriazinecarbonitriles useful as kinase inhibitors (2016-03-01),

7. 8940736 - Imidazotriazinecarbonitriles useful as kinase inhibitors (2015-01-27),

8. 8389527 - Substituted imidazopyridazines useful as kinase inhibitors (2013-03-05),

9. 7968577 - Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof (2011-06-28),

10. 7923556 - Phenyl-substituted pyrimidine compounds useful as kinase inhibitors (2011-04-12),

11. 7741289 - Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof (2010-06-22),

12. 7723336 - Fused heterocyclic compounds useful as kinase modulators (2010-05-25),

13. 7544808 - Tricyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof (2009-06-09),

14. 7541362 - Heterocyclic dihydropyrimidine compounds (2009-06-02),

15. 7439246 - Fused heterocyclic kinase inhibitors (2008-10-21),

Title: Wayne D Vaccaro: Pioneering Innovations in Medicine

Introduction:

Wayne D Vaccaro, a distinguished inventor based in Yardley, PA, has made significant contributions to the field of medicine with his inventive spirit and dedication. Holding an impressive total of 42 patents, Vaccaro is known for his groundbreaking work in developing novel carbazole compounds that serve as effective bromodomain inhibitors, opening new avenues for the treatment of various disorders.

Latest Patents:

Vaccaro's recent patents revolve around Carbazole compounds useful as bromodomain inhibitors, showcasing his expertise in creating pharmaceutically acceptable compositions that hold immense potential in treating a wide range of medical conditions. The innovative methods outlined in these patents reflect Vaccaro's commitment to pushing the boundaries of medical science for the betterment of society.

Career Highlights:

With a rich professional background, Vaccaro has lent his expertise to renowned companies such as Bristol-Myers Squibb Company and Schering Corporation. Through his tenure at these esteemed organizations, Vaccaro has spearheaded numerous projects aimed at revolutionizing the pharmaceutical industry and improving patient care.

Collaborations:

Throughout his career, Vaccaro has collaborated with esteemed peers in the field of medicine, including the likes of John W Clader and Tram N Huynh. These collaborations have not only enriched Vaccaro's own knowledge and skills but have also led to the creation of innovative solutions that have the potential to transform the healthcare landscape.

Conclusion:

In conclusion, Wayne D Vaccaro stands as a beacon of innovation in the realm of medicine, with his pioneering inventions and steadfast dedication paving the way for groundbreaking advancements in healthcare. His relentless pursuit of excellence and his collaborative spirit underscore his commitment to driving positive change and improving the lives of people worldwide.

This text is generated by artificial intelligence and may not be accurate.